Diabetes and endocrinology
NICE to review tirzepatide roll-out in three years, as limited NHS launch announced
MHRA urges pharmacists to be alert to signs of GLP-1 RA ‘misuse’
No link with metformin in dads and birth defects, finds review
Leaders cast their vision for the future of community pharmacy
CCA calls for pharmacy diabetes screening service
Replacing ultra-processed foods in diet may reduce type 2 diabetes risk
Food insecurity puts pregnant women at risk of both mental and physical illness
Darzi report: access to pharmacies 'a great strength' but 'at risk'
Diabetes drugs found to lower risk of dementia in large analysis
Engage with pharmacy teams on major conditions, leaders urge government
Government pauses work on ‘major conditions’ strategy
One third of ‘soups and shakes’ programme finishers in type 2 diabetes remission
Statin tops NHS prescribing once again as total number of items continues to increase
‘Soup and shakes’ diet programme being rolled out across England
Semaglutide helps heart failure symptoms in patients with obesity and type 2 diabetes
GLP-1 receptor agonists not linked to suicidal thoughts, PRAC concludes
Diabetes drug shows potential in treating Parkinson’s disease
Notification issued for multiple GLP1-RA shortages
Supporting patients with diabetes during Ramadan fasting
Long-term type 2 diabetes remission through weight loss ‘unsustainable’ for most
More Stories
